PFA-100 Responsive to Effect of Energy Drinks on Platelet Function
Completed · Not applicable
Conditions studied: Platelet Function, Thrombosis
In brief
This study evaluates the responsiveness of the Platelet Function Analyzer (PFA-100) to the effect of energy drinks on platelet function. Participants' will have blood drawn prior to and 60 minutes after ingesting 250ml of a commercially available sugar-free energy drink.
Key facts
- Study ID
- NCT02997111
- Run by
- St. Louis University
- People needed
- 13
- Starts
- 2017-02-14
- Expected to finish
- 2017-06-20
- Last updated by the study team
- 2017-06-22
Who can join
Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- a history of consuming at least one energy drink beverage in the past 6 months without adverse effects;
- engage in moderate to strenuous physical activity more than 3 days per week.
You may not qualify if…
- Known thromboembolic risk including protein C or S deficiency, anti-thrombin III deficiency, Factor V Leiden;
- history of thromboembolic event;
- current or previous anti-coagulation therapy, anti-platelet therapy, calcium antagonists; - current tricyclic antidepressant therapy, current selective serotonin re-uptake inhibitor therapy; antibiotic therapy; or famotidine therapy;
- acute illness;
- pregnancy;
- hemophilia;
- significant history of cardiovascular disease and/or diabetes mellitus;
- history of adverse effect of energy drinks.
- Inability to comply with pre-test dietary and activity requirements.
Where it is running
- Saint Louis University — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.